Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma

Overview

Journal Cancer Res

Specialty Oncology

Date 2023 May 30

PMID 37249584

Authors

Fanfan Fan

Jian Gao

Yue Zhao

Jun Wang

Lu Meng

Jiaqiang Ma

Teng Li

Han Han

Jinglei Lai

Zhendong Gao

Xiongfei Li

Ran Guo

Zhiwei Cao

Yang Zhang

Xiaoming Zhang

Haiquan Chen

Affiliations

Soon will be listed here.

Abstract

Significance: Comprehensive characterization of mast cells in lung adenocarcinoma elucidates their heterogeneity and identifies interplay between mast cells and CCR2+ T cells that is associated with a favorable prognosis.

Citing Articles

Analyze the Diversity and Function of Immune Cells in the Tumor Microenvironment From the Perspective of Single-Cell RNA Sequencing.

Ma L, Luan Y, Lu L Cancer Med. 2025; 14(5):e70622.

PMID: 40062730 PMC: 11891933. DOI: 10.1002/cam4.70622.

PDPN+ cancer-associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF-κB activation and the CCL2-ACKR1 axis.

Zhao Z, Sun H, Liu Y, Zhang Y, Wang X, Wang X MedComm (2020). 2025; 6(1):e70037.

PMID: 39764562 PMC: 11702504. DOI: 10.1002/mco2.70037.

DeSide: A unified deep learning approach for cellular deconvolution of tumor microenvironment.

Xiong X, Liu Y, Pu D, Yang Z, Bi Z, Tian L Proc Natl Acad Sci U S A. 2024; 121(46):e2407096121.

PMID: 39514318 PMC: 11573681. DOI: 10.1073/pnas.2407096121.

The pro-tumor activity of INTS7 on lung adenocarcinoma via inhibiting immune infiltration and activating p38MAPK pathway.

Li X, Lu F, Cao M, Yao Y, Guo J, Zeng G Sci Rep. 2024; 14(1):25636.

PMID: 39465338 PMC: 11514252. DOI: 10.1038/s41598-024-77093-3.

Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages.

Zhao Y, Gao J, Wang J, Fan F, Cheng C, Qian D Nat Commun. 2024; 15(1):7928.

PMID: 39256403 PMC: 11387495. DOI: 10.1038/s41467-024-52139-2.

References

Zhou T, Damsky W, Weizman O, McGeary M, Hartmann K, Rosen C . IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. Nature. 2020; 583(7817):609-614. PMC: 7381364. DOI: 10.1038/s41586-020-2422-6. View

Strouch M, Cheon E, Salabat M, Krantz S, Gounaris E, Melstrom L . Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res. 2010; 16(8):2257-65. PMC: 3122919. DOI: 10.1158/1078-0432.CCR-09-1230. View

Welsh T, Green R, Richardson D, Waller D, OByrne K, Bradding P . Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol. 2005; 23(35):8959-67. DOI: 10.1200/JCO.2005.01.4910. View

Lu T, Yang X, Shi Y, Zhao M, Bi G, Liang J . Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules. Cell Discov. 2020; 6:69. PMC: 7536439. DOI: 10.1038/s41421-020-00200-x. View

Stelekati E, Bahri R, DOrlando O, Orinska Z, Mittrucker H, Langenhaun R . Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity. 2009; 31(4):665-76. DOI: 10.1016/j.immuni.2009.08.022. View

Guo X, Zhang Y, Zheng L, Zheng C, Song J, Zhang Q . Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med. 2018; 24(7):978-985. DOI: 10.1038/s41591-018-0045-3. View

Cildir G, Yip K, Pant H, Tergaonkar V, Lopez A, Tumes D . Understanding mast cell heterogeneity at single cell resolution. Trends Immunol. 2021; 42(6):523-535. DOI: 10.1016/j.it.2021.04.004. View

Wu Y, Yang S, Ma J, Chen Z, Song G, Rao D . Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level. Cancer Discov. 2021; 12(1):134-153. DOI: 10.1158/2159-8290.CD-21-0316. View

Gajewski T, Schreiber H, Fu Y . Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013; 14(10):1014-22. PMC: 4118725. DOI: 10.1038/ni.2703. View

10.

Yang F, Feng W, Wang H, Wang L, Liu X, Wang R . Monocyte-Derived Leukemia-Associated Macrophages Facilitate Extramedullary Distribution of T-cell Acute Lymphoblastic Leukemia Cells. Cancer Res. 2020; 80(17):3677-3691. DOI: 10.1158/0008-5472.CAN-20-0034. View

11.

Pittoni P, Tripodo C, Piconese S, Mauri G, Parenza M, Rigoni A . Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. Cancer Res. 2011; 71(18):5987-97. DOI: 10.1158/0008-5472.CAN-11-1637. View

12.

Loberg R, Ying C, Craig M, Yan L, Snyder L, Pienta K . CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia. 2007; 9(7):556-62. PMC: 1939930. DOI: 10.1593/neo.07307. View

13.

Di Pilato M, Kfuri-Rubens R, Pruessmann J, Ozga A, Messemaker M, Cadilha B . CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment. Cell. 2021; 184(17):4512-4530.e22. PMC: 8719451. DOI: 10.1016/j.cell.2021.07.015. View

14.

Fu F, Zhang Y, Wen Z, Zheng D, Gao Z, Han H . Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions. J Thorac Oncol. 2019; 14(12):2133-2142. DOI: 10.1016/j.jtho.2019.08.002. View

15.

Zhao Y, Shang J, Gao J, Han H, Gao Z, Yan Y . Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma. Front Immunol. 2022; 13:921761. PMC: 9283781. DOI: 10.3389/fimmu.2022.921761. View

16.

Clara J, Monge C, Yang Y, Takebe N . Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat Rev Clin Oncol. 2019; 17(4):204-232. DOI: 10.1038/s41571-019-0293-2. View

17.

Ben-Baruch Morgenstern N, Ballaban A, Wen T, Shoda T, Caldwell J, Kliewer K . Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission. J Allergy Clin Immunol. 2022; 149(6):2062-2077. PMC: 9177790. DOI: 10.1016/j.jaci.2022.02.025. View

18.

Engblom C, Pfirschke C, Pittet M . The role of myeloid cells in cancer therapies. Nat Rev Cancer. 2016; 16(7):447-62. DOI: 10.1038/nrc.2016.54. View

19.

Rodriguez Cetina Biefer H, Heinbokel T, Uehara H, Camacho V, Minami K, Nian Y . Mast cells regulate CD4 T-cell differentiation in the absence of antigen presentation. J Allergy Clin Immunol. 2018; 142(6):1894-1908.e7. PMC: 6454881. DOI: 10.1016/j.jaci.2018.01.038. View

20.

Galli S, Nakae S, Tsai M . Mast cells in the development of adaptive immune responses. Nat Immunol. 2005; 6(2):135-42. DOI: 10.1038/ni1158. View